simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
1.0 /2024.05.01
Unknown other active
Quick answer
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib for Gastrointestinal Stromal Tumors is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Gastrointestinal Stromal Tumors
- Phase
- Unknown
- Modality
- other
- Status
- active